Pulmonology Medical News about Pulmonary Disease, Chronic Obstructive

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist Inhaler
International Journal of COPD, 10/15/09

Hodder R et al. – In comparative studies with DPIs, the total satisfaction score was statistically significantly higher than for the Turbuhaler DPI, but only the performance domain of satisfaction was clinically significantly higher for Respimat SMI. Whether the observed higher levels of patient satisfaction reported with Respimat SMI might be expected to result in improved adherence to therapy and thus provide benefits consistent with those recently shown to be associated with sustained bronchodilator treatment in patients with COPD remains to be proven.

<< Previous
Sequential comparison of tiotropium to high-dose ipratropium in...

Next >>
Impact of Socioeconomic Status, Race, and Ethnicity on Quality of...